{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:17:58Z","timestamp":1769073478297,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC0105207"],"award-info":[{"award-number":["2016YFC0105207"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1136\/ijgc-2019-000317","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T07:55:15Z","timestamp":1563436515000},"page":"1264-1270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"Meng","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiansun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-000317_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2019-000317_bb0015","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2019-000317_bb0020","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1470-2045(09)70290-6","article-title":"Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Tangjitgamol","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2019-000317_bb0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2019-000317_bb0045","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IGC.0b013e3182643ba0","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis","volume":"22","author":"Sorbe","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000317_bb0050","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0055","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.brachy.2017.11.012","article-title":"Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma","volume":"17","author":"Stahl","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2019-000317_bb0065","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ygyno.2004.03.002","article-title":"Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation","volume":"93","author":"Fanning","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2007.08.072","article-title":"A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma","volume":"108","author":"Lachance","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2018.11.005","article-title":"National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer","volume":"152","author":"Suidan","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0080","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","article-title":"American Society of Clinical Oncology Statement: a conceptual framework to assess the value of cancer treatment options","volume":"33","author":"Schnipper","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2019-000317_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-000317_bb0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.brachy.2016.06.012","article-title":"Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: results of an updated period analysis of SEER data","volume":"15","author":"Modh","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2019-000317_bb0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijrobp.2011.05.052","article-title":"Trends in the utilization of adjuvant vaginal cuff brachytherapy and\/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end-results study","volume":"83","author":"Patel","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-000317_bb0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.radonc.2016.12.003","article-title":"Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk stage I endometrial cancer","volume":"122","author":"Harkenrider","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2016.10.028","article-title":"Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis","volume":"144","author":"Gupta","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0115","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1200\/JCO.2013.48.8023","article-title":"Long-term outcomes after pelvic radiation for early-stage endometrial cancer","volume":"31","author":"Onsrud","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000317_bb0120","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2019-000317_bb0125","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-000317_bb0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5114\/jcb.2018.75595","article-title":"Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma","volume":"10","author":"Sunil","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1136\/ijgc-2019-000317_bb0135","first-page":"926","article-title":"Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer","volume":"15","author":"Cengiz","year":"2005","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-000317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:19:16Z","timestamp":1753222756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24002755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1048891X24002755"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-000317","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-000317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}